Indian Finance Minister Issues Warnings Regarding Crypto
The Indian finance minister suggested against using cryptocurrency.The law enforcement organization blocked the assets of two crypto exchanges.At a BJP Economic Cell event on Saturday,...
Strong Buy
or
Turning Point News & Analysis
-
-
German Power Prices Hit Fresh Record as Gas Continues to Surge
(Bloomberg) -- Europe’s benchmark power price rose to a record for a fifth consecutive trading session as there are no signs of the natural gas rally slowing down. German year-ahead power...
-
Turning Point Therapeutics Provides Regulatory Update for Repotrectinib for the Treatment of ROS1+ Advanced NSCLC
SAN DIEGO, July 27, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ:TPTX), a clinical-stage precision oncology company designing and developing novel targeted therapies...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.05%
Investing.com – U.S. equities were lower at the close on Friday, as losses in the Technology, Consumer Goods and Consumer Services sectors propelled shares lower. At the close in NYSE, the...
-
Midday Movers: Tesla, Kohl's, Coinbase and More
By Liz Moyer Investing.com -- U.S. stocks are lower on Friday after a stronger than expected jobs report. Here are the midday movers for June 3: Tesla Inc (NASDAQ:TSLA) shares fell 8%...
-
Bristol Myers Squibb's Turning Point Offer Fair, Says Stifel
By Sam Boughedda On Friday, it was announced that Bristol-Myers Squibb (NYSE:BMY) will acquire Turning Point Therapeutics (NASDAQ:TPTX) for $4.1 billion or $76 a share, more than double...
-
Pre-Open Stock Movers 06/03: Turning Point Doubles on Takeover; Tesla Falls as Musk Worried About Economy, Cutting 10% of Staff
Pre-Open Stock Movers: Turning Point Therapeutics Inc . (NASDAQ:TPTX) 117% HIGHER; Bristol Myers Squibb (NYSE:BMY) and Turning Point Therapeutics Inc. today announced a definitive merger...
-
Bristol Myers Squibb Announces $4.1B Deal for Turning Point Therapeutics
By Daniel Shvartsman Investing.com -- Pharmaceutical giant Bristol Myers Squibb Company (NYSE:BMY) announced a $4.1 billion deal for Turning Point Therapeutics Inc (NASDAQ:TPTX) on...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
